| NTRA |
Natera, Inc. |
0 |
5.86% |
|
|
|
|
|
N/A |
0.00% |
37.21% |
10.51% |
|---|
| VCYT |
Veracyte, Inc. |
0 |
5.41% |
|
|
|
|
|
N/A |
0.00% |
60.74% |
32.45% |
|---|
| QGEN |
Qiagen N.V. |
0 |
4.66% |
|
|
|
|
|
N/A |
0.00% |
31.38% |
29.73% |
|---|
| TECH |
Bio-Techne Corporation |
0 |
4.57% |
|
|
|
|
|
N/A |
0.00% |
43.41% |
43.19% |
|---|
| BNTX |
BioNTech SE |
0 |
4.45% |
|
|
|
|
|
N/A |
0.00% |
44.45% |
21.33% |
|---|
| A |
Agilent Technologies, Inc. |
0 |
4.42% |
|
|
|
|
|
N/A |
0.00% |
29.89% |
19.72% |
|---|
| BMRN |
BioMarin Pharmaceutical Inc. |
0 |
4.10% |
|
|
|
|
|
N/A |
0.00% |
39.42% |
43.50% |
|---|
| ARWR |
Arrowhead Pharmaceuticals, Inc. |
0 |
4.10% |
|
|
|
|
|
N/A |
0.00% |
50.78% |
12.70% |
|---|
| ILMN |
Illumina, Inc. |
0 |
4.09% |
|
|
|
|
|
N/A |
0.00% |
42.66% |
21.85% |
|---|
| SRPT |
Sarepta Therapeutics, Inc. |
0 |
4.09% |
|
|
|
|
|
N/A |
0.00% |
96.18% |
43.24% |
|---|
| BEAM |
Beam Therapeutics Inc. |
0 |
3.76% |
|
|
|
|
|
N/A |
0.00% |
73.26% |
43.47% |
|---|
| CRSP |
CRISPR Therapeutics AG |
0 |
3.68% |
|
|
|
|
|
N/A |
0.00% |
66.36% |
51.55% |
|---|
| ALNY |
Alnylam Pharmaceuticals, Inc. |
0 |
3.51% |
|
|
|
|
|
N/A |
0.00% |
38.65% |
25.91% |
|---|
| RARE |
Ultragenyx Pharmaceutical Inc. |
0 |
3.39% |
|
|
|
|
|
N/A |
0.00% |
45.18% |
4.48% |
|---|
| LEGN |
Legend Biotech Corporation |
0 |
3.27% |
|
|
|
|
|
N/A |
0.00% |
48.96% |
17.65% |
|---|
| MRNA |
Moderna, Inc. |
0 |
3.23% |
|
|
|
|
|
N/A |
0.00% |
78.65% |
45.13% |
|---|
| TXG |
10x Genomics, Inc. |
0 |
2.97% |
|
|
|
|
|
N/A |
0.00% |
74.22% |
15.06% |
|---|
| RNA |
Avidity Biosciences, Inc. |
0 |
2.82% |
|
|
|
|
|
N/A |
0.00% |
80.63% |
42.36% |
|---|
| 1548.HK |
GENSCRIPT BIOTECH CORP |
|
2.76% |
|
|
|
|
|
|
|
|
|
|---|
| MYGN |
Myriad Genetics, Inc. |
0 |
2.47% |
|
|
|
|
|
N/A |
0.00% |
59.80% |
16.55% |
|---|
| NTLA |
Intellia Therapeutics, Inc. |
0 |
2.36% |
|
|
|
|
|
N/A |
0.00% |
94.17% |
49.29% |
|---|
| GILD |
Gilead Sciences, Inc. |
0 |
2.31% |
|
|
|
|
|
N/A |
0.00% |
28.60% |
27.35% |
|---|
| CDNA |
CareDx, Inc |
0 |
2.17% |
|
|
|
|
|
N/A |
0.00% |
173.22% |
27.97% |
|---|
| RCKT |
Rocket Pharmaceuticals, Inc. |
0 |
2.09% |
|
|
|
|
|
N/A |
0.00% |
179.98% |
66.59% |
|---|
| VRTX |
Vertex Pharmaceuticals Incorporated |
0 |
1.87% |
|
|
|
|
|
N/A |
0.00% |
27.37% |
15.71% |
|---|
| QURE |
uniQure N.V. |
0 |
1.59% |
|
|
|
|
|
N/A |
0.00% |
201.50% |
99.31% |
|---|
| VIR |
Vir Biotechnology, Inc. |
0 |
1.34% |
|
|
|
|
|
N/A |
0.00% |
82.26% |
26.52% |
|---|
| MRVI |
Maravai LifeSciences Holdings, Inc. |
0 |
1.33% |
|
|
|
|
|
N/A |
0.00% |
N/A |
29.75% |
|---|
| PSTX |
POSEIDA THERAPEUTICS INC |
|
1.26% |
|
|
|
|
|
|
|
|
|
|---|
| SGMO |
Sangamo Therapeutics, Inc. |
0 |
0.96% |
|
|
|
|
|
N/A |
0.00% |
230.17% |
36.45% |
|---|
| PACB |
Pacific Biosciences of California, Inc. |
0 |
0.95% |
|
|
|
|
|
N/A |
0.00% |
532.32% |
13.52% |
|---|
| FLGT |
Fulgent Genetics, Inc. |
0 |
0.75% |
|
|
|
|
|
N/A |
0.00% |
44.99% |
23.25% |
|---|
| VERV |
VERVE THERAPEUTICS INC |
|
0.71% |
|
|
|
|
|
|
|
|
|
|---|
| RGNX |
REGENXBIO Inc. |
0 |
0.66% |
|
|
|
|
|
N/A |
0.00% |
113.51% |
23.34% |
|---|
| ALLO |
Allogene Therapeutics, Inc. |
0 |
0.59% |
|
|
|
|
|
N/A |
0.00% |
588.56% |
52.37% |
|---|
| SANA |
Sana Biotechnology, Inc. |
0 |
0.40% |
|
|
|
|
|
N/A |
0.00% |
271.10% |
15.09% |
|---|
| TSVT |
2SEVENTY BIO INC |
|
0.29% |
|
|
|
|
|
|
|
|
|
|---|
| CRBU |
Caribou Biosciences, Inc. |
0 |
0.27% |
|
|
|
|
|
N/A |
0.00% |
314.60% |
24.65% |
|---|
| EDIT |
Editas Medicine, Inc. |
0 |
0.20% |
|
|
|
|
|
N/A |
0.00% |
352.98% |
35.10% |
|---|
| LYEL |
Lyell Immunopharma, Inc. |
0 |
0.17% |
|
|
|
|
|
N/A |
0.00% |
151.63% |
12.35% |
|---|
| E |
Eni S.p.A. |
0 |
0.01% |
|
|
|
|
|
N/A |
0.00% |
N/A |
35.74% |
|---|